Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 26, 2022; 10(12): 3739-3753
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3739
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3739
Figure 1 Survival curves.
A: Progression-free survival (PFS); B: Overall survival (OS); C: Chemotherapy-free interval (CFI) after secondary surgery for platinum-resistant recurrent epithelial ovarian carcinoma. Median PFS was 10 (95%CI: 8.27-11.73) months. Median OS was 28 (95%CI: 12.75-43.25) months. Median CFI was 9 (95%CI: 8.06-9.94) months.
- Citation: Zhao LQ, Gao W, Zhang P, Zhang YL, Fang CY, Shou HF. Surgery in platinum-resistant recurrent epithelial ovarian carcinoma. World J Clin Cases 2022; 10(12): 3739-3753
- URL: https://www.wjgnet.com/2307-8960/full/v10/i12/3739.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i12.3739